Last edition
News about "Astellas Pharma"
Axcelead DDP Signs Drug Discovery Service Deal with Astellas for Targeted Protein Degraders
Under the agreement, Axcelead DDP will support Astellas’ targeted protein degrader discovery utilizing DegLeadTM Platform and contribute to the generation of breakthrough new drug candidate compounds.
Astellas Pharma | 27/12/2024 | By Aishwarya
Astellas Pharma and YASKAWA Sign MOU to Explore Innovative Cell Therapy Ecosystem
Astellas will contribute cell manufacturing technology, clinical development, and regulatory insights related to cell therapy, while YASKAWA will provide and develop robotics and factory automation technologies.
Astellas Pharma | 21/05/2024 | By Abha | 106
Astellas Signs License Deal with Poseida to Develop Novel Allogeneic Cell Therapies
Astellas Pharma Inc. has announced that Xyphos Biosciences, Inc., a wholly owned subsidiary of Astellas and Poseida have signed a research collaboration and license agreement to develop novel convertibleCAR programs by combining the innovative cell therapy platforms from each of the companies.
Astellas Pharma | 03/05/2024 | By Aishwarya | 131
Invenra Signs Research Deal with Astellas Pharma to Boost Bispecific Therapeutic Research
Invenra Inc. has forged a strategic research agreement with Astellas Pharma, a global pharmaceutical company with a vision to turn innovative science into value for patients.
Astellas Pharma | 10/04/2024 | By Aishwarya | 191
Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm
Astellas Pharma announced that Astellas B.V., Astellas Pharma Europe B.V., and Astellas’ subsidiaries in the Netherlands have decided to sell and transfer the manufacturing plant located in Meppel to Delpharm Industries.
Astellas Pharma | 30/05/2023 | By Sudeep Soparkar | 283
Astellas Pharma buys Iveric Bio for $5.9 Bn
The deal marks the fifth major overseas acquisition by Astellas
Astellas Pharma | 02/05/2023 | By Sudeep Soparkar | 550
The four companies will aim to promote the use of more environmentally friendly packaging for pharmaceutical products by sharing knowledge on packaging technologies
Astellas Pharma | 22/12/2022 | By Sudeep Soparkar | 648
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy